Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer-Reference-Cited by-同舟云学术

Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer

Published:2014-04-09 Issue:1 Volume:7 Page:
ISSN:1757-2215
Container-title:Journal of Ovarian Research
language:en
Short-container-title:J Ovarian Res

Author:

Kawaguchi Hiroshi,Terai Yoshito,Tanabe Akiko,Sasaki Hiroshi,Takai Masaaki,Fujiwara Satoe,Ashihara Keisuke,Tanaka Yoshimichi,Tanaka Tomohito,Tsunetoh Satoshi,Kanemura Masanori,Ohmichi Masahide

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology,Oncology

Link

https://link.springer.com/content/pdf/10.1186/1757-2215-7-38.pdf

Reference35 articles.

1. Dunton CJ: New options for the treatment of advanced ovarian cancer. Semin Oncol 1997, 24: S5–2-S5–11.

2. ten Bokkel Huinink W, Gore M, Carmichael J, Gordon A, Malfetano J, Hudson I, Broom C, Scarabelli C, Davidson N, Spanczynski M, Bolis G, Malmström H, Coleman R, Fields SC, Heron JF: Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. J Clin Oncol 1997, 15: 2183–2193.

3. Rose PG, Blessing JA, Mayer AR, Homesley HD: Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 1998, 16: 405–410.

4. Markman M, Kennedy A, Sutton G, Hurteau J, Webster K, Peterson G, Kulp B, Belinson J: Phase II trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent. Gynecol Oncol 1998, 70: 272–274. 10.1006/gyno.1998.5065

5. Markman M, Blessing JA, Moore D, Ball H, Lentz SS: Altretamine (hexamethylmelamine) in platinum-resistant and platinum-refractory ovarian cancer: a Gynecologic Oncology Group phase II trial. Gynecol Oncol 1998, 69: 226–229. 10.1006/gyno.1998.5016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cisplatin in Liver Cancer Therapy;International Journal of Molecular Sciences;2023-06-29

2. Chemotherapy-induced metastasis: molecular mechanisms and clinical therapies;Acta Pharmacologica Sinica;2023-05-11

3. Nanoparticle-Based Combination Therapy for Ovarian Cancer;International Journal of Nanomedicine;2023-04

4. Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601;Anti-Cancer Drugs;2022-12-05

5. Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma;Frontiers in Oncology;2022-11-30